Venture capital firm

Bold Capital Partners

Venture capital firm investing in emerging science and technology companies

Write a review

Science
Construction
Manufacturing
Biotechnology
+5 more

Visit Website Get introducedRequest an introduction Write a Review

Own this listing? Claim it

TrustList summary

Bold Capital Partners, known as BOLD, is a venture capital firm that seeks entrepreneurs with an ambitious vision. It looks for emerging science and technology that could disrupt large markets.

Products and services

Venture investment: backs founders working on new science and technology.
Convergence focus: targets companies at the meeting point of physical, digital, virtual and biological technology.
Career opportunities: lists jobs at the firm and its portfolio companies.

Clients

The firm is interested in companies tackling large human challenges. It says the technologies it backs are advancing at an exponential rate. The site showcases portfolio companies that are reshaping their industries, and invites readers to look at careers at the firm or at the companies it works with.

Summary written by TrustList from the business's own published information, Oct 2026.

Gallery

2 images - click to enlarge

Rankings

Bold Capital Partners is ranked on 2 TrustList rankings: #20 on 1 and #39 on 1.

Every ranking orders its listings by their reviews, how complete the profile is and the Trust Score. Bold Capital Partners has no reviews yet and 3 of the 10 profile details we look for. Where no listing on a page has been reviewed, the order follows the profiles alone.

Venture capital firm · 2 rankings

#20of 64
Los angeles
It is the only one of the top 58 here listing funding round and one of 2 here listing construction.
Of the top 58 here, 10 also cover partners and 9 also cover growth stage; 20 also work in New York City and 9 also work in San Francisco.
Behind Blue Bear Capital, ahead of Cain International.
#39of 110
Boston
It is the only one of the top 69 here listing manufacturing and series f.
Of the top 69 here, 11 also cover biotech and 10 also cover seed stage; 21 also work in London and 17 also work in Silicon Valley.
Behind Boehringer Ingelheim Venture Fund, ahead of Boston Millennia Partners.